Insulin‐like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)
Authors:
- 1 August 1990
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 144 (2) , 244-253
Abstract
The cell surface of human fibroblasts contains not only type IIGF receptors but at least two forms of IGFBPs. Studies were undertaken to analyze the mechanisms by which these IGFBPs alter IGF‐I‐cell surface interactions. Human fetal fibroblasts (GM10) and a human glioblastoma cell line (1690) were chosen for analysis. During assays to quantify [125l]‐IGF‐l binding, both cell lines were shown to release IGFBPs into the binding assay buffer. Under equilibrium conditions, [125I]‐IGF‐I preferentially associates with IGFBPs in the assay buffer (up to 40% of the [125I]‐IGF‐I added) since they have a higher affinity than type IIGF receptors or IGFBPs associated with the cell surface. Likewise the addition of increasing concentrations of unlabeled IGF‐I results in preferential competition for binding to assay buffer IGFBPs. This results in a repartitioning of the [125I]‐IGF‐I that is bound to assay buffer IGFBPs onto cell surface binding sites. The degree of repartitioning is quantitatively related to the amount of [125I]‐IGF‐I bound to released IGFBPs. When cultures are exposed to cycloheximide before the binding assay, both the amount of IGFBPs that are released into the assay buffer and the amount of [125 I]‐IGF‐l that is repartitioned are decreased. In contrast when [Gln3, Ala4, Tyr15, Leu16]‐IGF‐l (IQAYLj‐IGF‐I, an IGF analog that has unaltered affinity for type I IGF receptors) is iodinated and tested, the competition curve with unlabeled IGF‐I shows no repartitioning effect. This form of IGF can be used to quantify type I receptor number independent of the presence of IGFBPs. IGF‐I and the [QAYL]‐IGF‐I compete equally with the [125I]‐[QAYL]‐IGF‐I for binding to cell surfaces, whereas unlabeled [QAYL]‐IGF‐I is > 25‐fold less potent compared to IGF‐I in competing with [125I]‐IGF‐I for cell surface binding. Specific binding of [125I]‐[QAYL]‐IGF‐I to GM10 and 1690 cell surfaces is < 20% of [125I]‐IGF‐I binding. These findings suggest that IGFBPs that are present on human fibroblast surfaces represent a large portion of the IGF binding sites. We conclude that the amount of IGFBPs released into assay buffer is a major determinant of the repartitioning of [125I]‐IGF‐I to cell surface binding sites and that both cell surface and assay buffer IGFBPs modulate type I IGF receptor binding.Keywords
This publication has 29 references indexed in Scilit:
- Actions of insulin‐like growth factor‐I on the B104 neuronal cell line: Effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand bindingJournal of Cellular Physiology, 1989
- Characterization of the increased biological potency in BALB/C 3T3 cells of two analogs of human insulinlike growth factor I which have reduced affinity for the 28 K cell‐derived binding proteinJournal of Cellular Physiology, 1989
- An acid-stable insulin-like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cellsJournal of Endocrinology, 1989
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblastsBiochemical and Biophysical Research Communications, 1988
- Cloning, characterization, and expression of a human insulin-like growth factor binding proteinBiochemical and Biophysical Research Communications, 1988
- Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.Journal of Clinical Investigation, 1986
- Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.Journal of Clinical Investigation, 1986
- Somatomedin (Insulin-Like Growth Factors)-Binding ProteinsHormone Research, 1986
- Density‐associated loss of functional receptors for somatomedin‐C/insulinlike growth factor I (SM‐C/IGF‐I) on cultured human fibroblast monolayersJournal of Cellular Physiology, 1984
- Receptors for insulinlike growth factor I are defective in fibroblasts cultured from a patient with leprechaunism.Journal of Clinical Investigation, 1981